Myriad Genetics | MYGN - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Agilent USD 465M 11M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Bruker USD 242.1M 5.1M 2026-03
Danaher USD 1.86B 166M 2026-03
Illumina USD 272M 11M 2026-03
J&J USD 6.03B 719M 2026-03
Mettler Toledo International USD 258.33M 1.5M 2026-03
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Quidel USD 199.3M 4.9M 2026-03
Repligen USD 76.54M 2.17M 2026-03
Revvity USD 253.88M 2.15M 2026-03
Standard Biotools USD 21.55M 5.05M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Veracyte USD 50.84M 7.53M 2026-03
Waters USD 394M 153.99M 2026-03